Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5863072 | 0.97 | NPC1 (0.45) | FYNNPC1RAB9ASMN1; SMN2CACNA1H | |
| SCHEMBL5863083 | 0.94 | ALDH1A1 (0.50) | FYNNPC1RAB9ASMN1; SMN2CACNA1H | |
| Oxalic Acid SCHEMBL5863262 | 0.88 | FYN (0.46) | FYNNPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL5863067 | 0.87 | HTT (0.44) | NPC1RAB9ASMN1; SMN2ALDH1A1MCHR1 | |
| Hydrochloric Acid SCHEMBL5863069 | 0.87 | ROCK2 (0.49) | FYNNPC1RAB9ASMN1; SMN2CACNA1H | |
| SCHEMBL6252851 | 0.86 | KDM4E (0.43) | SMN1; SMN2ALDH1A1KMT2AKDM4EL3MBTL1 | |
| Oxalic Acid SCHEMBL5863102 | 0.86 | KDR (0.44) | FYNNPC1RAB9ASMN1; SMN2HPGD | |
| Oxalic Acid SCHEMBL5863058 | 0.83 | ROCK2 (0.48) | FYNNPC1RAB9ASMN1; SMN2CACNA1H | |
| SCHEMBL5863052 | 0.83 | KDM4E (0.45) | FYNNPC1RAB9ASMN1; SMN2ALDH1A1 | |
| Oxalic Acid SCHEMBL5863143 | 0.83 | FYN (0.46) | FYNNPC1RAB9ASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132456-B2 | MCH receptor antagonists | ELI LILLY AND COMPANY (US) | 2006-11-07 | — | — | US | disclosed |
| US-20060052449-A1 | Novel mch receptor antagonists | ELI LILLY AND COMPANY | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052449-A1 | Novel mch receptor antagonists | MCHR1, MCHR2, MC1R | FYN 3249/4885NPC1 698/4885RAB9A 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.